This cohort received either no vaccine, dendritic cell vaccine, or APCs isolated from the tumor microenvironment derived from GFP+HSCs, GFP+CCR2+HSC-derived cells, or GFP+CCR2−HSC-derived cells. The gene discussed is CCR2; the disease is neoplasm.